INSIGHTS ON DRUG DEVELOPMENT

• Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load

  Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.

• Real-Time Growth Monitoring Of Spheroids In Round Bottom Microplates

  Real-time spheroid monitoring combines brightfield and fluorescence imaging with automated analysis. Find out how this workflow enhances reproducibility and supports high-content 3D cell culture applications.

• Remote Measurements For Bulk Samples

  Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.

• Application Of LC-UV/MS Workflows To Increase Efficiency

  Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.

• Accelerating mRNA Therapy Production With Digital Innovation

  10/21/2025

  Scaling mRNA therapies requires more than innovation—it demands precision. Discover how digital tools like automation and analytics are helping life science companies streamline production.

• Little Patients, Big Challenges: Developing Pediatric Formulations

  5/12/2025

  Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.

• mRNA Manufacturing With Fed-Batch In Vitro Transcription

  2/13/2026

  A milliliter-scale approach to IVT optimization reveals how controlled feeding, precise pH management, and real-time monitoring can boost mRNA yield and streamline scale-up to larger bioreactor volumes.

• Scientific Data Is Not AI‑Ready By Default

  6/26/2026

  Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.

• The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly

  3/3/2025

  In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.